INTEREST in the management of patients with coronary artery disease has focused on subgroups of patients defined by arteriographic findings. In the Veterans Administration Cooperative Study, the first subgroup with significantly improved survival when managed surgically and followed for 2-3 years was that of patients with disease of the left main coronary artery.1 Other reports, including the only other randomized controlled study,2 confirmed this finding.
INTEREST in the management of patients with coronary artery disease has focused on subgroups of patients defined by arteriographic findings. In the Veterans Administration Cooperative Study, the first subgroup with significantly improved survival when managed surgically and followed for 2-3 years was that of patients with disease of the left main coronary artery.1 Other reports, including the only other randomized controlled study,2 confirmed this finding.
Patients with left main disease are not a homogeneous group.3'4 Those with more severe stenosis or with an abnormality of left ventricular (LV) function were reported to have a worse prognosis. 4 In coronary heart disease patients without left main disease, a benefit from surgery has also been reported in subgroups based on clinical criteria alone.5 In this report, we examine the effects of bypass surgery on survival and on the incidence of myocardial infarction (MI) in angiographically and clinically defined subgroups of patients with left main coronary artery disease.
Methods The screening and selection of patients have been described."6' 6 7In brief, during [1972] [1973] [1974] 686 tients who had a significant stenosis (at least 50% reduction of the luminal diameter) of the left main coronary artery. The coronary arteriograms were reviewed to confirm the presence of a significant left main lesion and to assess the degree of stenosis. MIs that occurred after randomization were identified in accordance with definitions used by the Coronary Drug Project8 and by Hultgren et al.9 (appendix A). ECGs and autopsy protocols, as well as most left ventriculograms, were reviewed centrally (appendix B).
In the left main subgroup, 43 patients were assigned to medical treatment and 48 to surgical treatment. Twenty-one medical and two surgical patients did not adhere to assigned therapy. * However, most of the crossovers from the medical to the surgical group occurred after 42 months of follow-up, when study clinicians were informed that a significant benefit from surgery had been identified. Therefore, survival comparisons for left main patients have been limited to the first 42 months of follow-up, because beyond that point the cumulative crossover rate increased markedly ( fig. 1 'Test of overall difference in survival between treatment groups within a subgroup category.
-'Test of equality of treatment effects across subgroup categories. §Surgical minus medical. p = 0. 27), presumably because of the lack of power in the small samples.
In the high-risk tercile (n = 33), there is a significant survival benefit from surgery (88% vs 44%, p = 0.004), while in the middle-risk subgroup (n = 24), the surgical benefit is only marginally significant (92% vs 58%, p = 0.073). The low-risk tercile shows a slight nonsignificant disadvantage from surgery (83% vs 93%) ( fig. 3 ). However, it would be difficult to find any subgroup of patients with left main disease whose survival rate is better than the 93% observed in this small medical group (n = 15). The test of the homogeneity of the treatment differences across the terciles was significant (p = 0.035)'.
Forty of 43 operated patients (93%) who survived 1 year had angiography approximately 1 year after surgery to visualize the vein grafts. Three patients died during the first postoperative year of follow-up. The heterogeneity of patients with left main lesions has been pointed out by several observers3' 21 but disputed by others,'9, 22 insofar as the need for surgical management is concerned. Conley et al., 4 in their study of the natural history of the disease, found that medically treated patients with left main lesions less than 70% had survival rates similar to those of patients with three-vessel disease without left main lesions. A poorer prognosis was associated not only with lesions of 70% or greater, but also with certain noninvasive risk factors, including a history of congestive failure, the presence of rest pain, cardiomegaly, ST-segment depression on the resting ECG, and an abnormal left ventricular contraction pattern.
Campeau et al.17 compared the survival of subsets of medically and surgically treated patients in a nonrandomized retrospective study and found significantly improved survival after surgery in patients with left main stenoses greater than 50% and associated stenoses greater than 70% of the right coronary artery.'7 However, survival remained significantly higher in operated than in unoperated patients whether luminal diameter of the left main artery was reduced to 50-60% or to more than 70%. They also found a significant benefit for surgery in two left main subgroups: LV ejection fraction of 45% or greater and LV end-diastolic pressure less than 20 mm Hg. No significant treatment differences were observed for the more severe categories of ejection fraction or LV end-diastolic pressure.
In the randomized controlled study by the European group, significantly improved survival at 3 years was reported in operated patients with left main stenosis greater than 50% and LV ejection fraction greater than 50%.2 In that study, no subgroup analyses were reported, probably because only 59 patients had left main disease.
The Veterans Administration results show a significant benefit for surgery in three subgroups of patients with left main disease: stenosis greater than 75%, abnormal LV function, and high noninvasive risk. Despite the lack of statistical significance in the subgroups with normal LV function and lesser left main stenosis, surgery had a beneficial effect in these subgroups also.
Similarly, patients in both the noninvasive high-and middle-risk terciles have improved survival with surgical treatment. Medical patients in the noninvasive lowrisk tercile had a 93% 42-month survival, which might be difficult to improve upon by any form of treatment. Indeed, the treatment comparison shows that for this subgroup, surgery may be detrimental. The small, nonsignificant survival disadvantage for surgery in the low-risk tercile indicates that some patients with left medically. This result agrees with our finding in the larger group of patients without left main disease.5 Table 3 indicates that there is a marginal relationship between noninvasively derived prognostic risk factors and those identified by invasive or angiographic techniques. Thus, severity of anatomic disease and of physiologic dysfunction can be predicted to some extent by classifying patients in accordance with noninvasive criteria. This relationship may be part of the explanation for the clearcut differences in prognosis of the natural history of the disease in the control group when they are divided into the three noninvasive risk terciles.
Chaitman and associates23 reported the heterogeneity of patients with left main lesions in a study of 1 172 nonrandomized operated cases by identifying several factors that delineate patients at high and low operative risk. For example, while overall operative mortality was 4.2%, patients in the high-risk group, delineated by left coronary artery dominance, had an operative mortality of 12%. In our study, overall operative mortality was 6.5% (three of 46), but for patients with left coronary artery dominance, mortality was 14% (one of seven).
Perioperative MI rates after aortocoronary bypass surgery have varied from 4% to 27%, depending on methods of detection and diagnostic criteria used, selection of patients, and anesthetic, surgical and myocardial preservation techniques.22440 For patients with left main lesions, MI rates of 3%,20 14%' 1 and 15%41 have been reported, using more stringent diagnostic criteria than ours. In accordance with the definitions in appendix A, the rate of perioperative MI in this study was 19.6%.
In our patients who underwent the operation between 1972 and 1974, bypass surgery did not appear to alter the incidence of MI significantly. Fatal MIs, both definite and suspected, were fewer among surgically randomized patients (6% vs 18.6%), but when the analysis was limited to definite MI, the rates were almost identical (6% vs 7%). Sudden death was not seen after surgery during the observation period, in contrast to a 14% incidence in medically randomized patients (p = 0.007). With the improvements in anesthetic and myocardial preservation techniques introduced after the close of this study, the reported incidence of perioperative MI for patients with coronary bypass surgery is considerably lower than that reported here.33
Randomized controlled trials of surgical procedures have been criticized when the number of patients who did not adhere to the assigned therapy becomes large.42 This problem is compounded when, during the course of the trial, a significant difference in outcome between surgical and nonsurgical treatment groups is identified. Ethical considerations require that these findings be made known to participants and to patients in the study, so that they may be offered the therapy that is proving to be more effective. When this happens, the value of the controlled trial is compromised because main disease have a favorable prognosis when treated 19 the randomization is impaired. To assure the validity VOL 66, No 1, JULY 1982 of the study, outcome comparisons between treatment groups were limited to 42 months of follow-up. This restriction avoids the problem of making too many assumptions and attempts to adjust for known discrepancies in the analysis of the data. 
